To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Fraud and abuse risks facing private equity investors in healthcare, life sciences
Sponsors are facing direct exposure and liability as a result of increased scrutiny by the Department of Justice and other enforcement agencies.
